drugset
drugset / Trial / NCT03186053

Sodium Creatine Phosphate in Heart Valve Surgery

NCT03186053 ↗

Unknown 250 enrolled Chinese Academy of Medical Sciences, Fuwai Hospital
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

To explore the effect of intraoperative sodium creatine phosphate on myocardial protection in patients undergoing valve surgery

Timeline

Start
2017-06-15
Primary completion
2018-07-01
Completion
2018-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium creatine phosphate Unknown 1 g —

Indications

heart valve disorder